LOGO
LOGO

Corporate News

Philip Morris Raises 2025 Adj. EPS Guidance

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Philip Morris International (PM) said it achieved record quarterly smoke-free gross profit and adjusted EPS in its third quarter. The company is on track to exceed 2024-26 growth targets and upgraded 2025 full-year adjusted EPS forecast. For 2025, the company now expects adjusted EPS, excluding currency, in a range of $7.36 - $7.46. Adjusted EPS is expected in a range of $7.46 - $7.56. Reported EPS is projected in a range of $7.39 - $7.49. The company expects net revenue growth of around 6% to 8% on an organic basis. No share repurchases are anticipated in 2025.

Third-quarter net income attributable to PMI increased to $3.48 billion from $3.08 billion, last year. Reported EPS grew 13.2% to $2.23. Adjusted EPS was up 17.3% to $2.24. Adjusted EPS excluding currency was up 13.1% to $2.16. Analysts on average expected the company to report profit per share of $2.10, for the quarter. Analysts' estimates typically exclude special items.

Third quarter net revenue was $10.85 billion, compared to $9.91 billion, last year. Organic growth was 5.9%, for the quarter. Analysts on average had estimated $10.66 billion in revenue.

Shares of Philip Morris are up 3% in pre-market trade on Tuesday.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update: May 11 – May 15, 2026

May 15, 2026 15:25 ET
Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.

Latest Updates on COVID-19